According to Dechra Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.96 B. In 2023 the company made a revenue of $0.96 B an increase over the years 2022 revenue that were of $0.82 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 | $0.96 B | 16.13% |
2022 | $0.82 B | -1.72% |
2021 | $0.84 B | 32.73% |
2020 | $0.63 B | 3.68% |
2019 | $0.61 B | 13.75% |
2018 | $0.53 B | 15.02% |
2017 | $0.46 B | 40.23% |
2016 | $0.33 B | 4.14% |
2015 | $0.32 B | -2.92% |
2014 | $0.32 B | 14.63% |
2013 | $0.28 B | -56.95% |
2012 | $0.66 B | 6.77% |
2011 | $0.62 B | 13.36% |
2010 | $0.55 B | -4.21% |
2009 | $0.57 B | -5% |
2008 | $0.60 B | 18.45% |
2007 | $0.51 B | 19.14% |
2006 | $0.42 B | 14.19% |
2005 | $0.37 B | 10.69% |
2004 | $0.34 B | 10.36% |
2003 | $0.30 B | 43.26% |
2002 | $0.21 B | 8.82% |
2001 | $0.19 B |